Bionano Genomics
BNGO
142 hedge funds and large institutions have $121M invested in Bionano Genomics in 2022 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 50 increasing their positions, 29 reducing their positions, and 19 closing their positions.
132% more call options, than puts
Call options by funds: $4.27M | Put options by funds: $1.84M
72% more repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 29
21% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 19
1% more funds holding
Funds holding: 140 → 142 (+2)
0.26% more ownership
Funds ownership: 27.55% → 27.81% (+0.26%)
18% less capital invested
Capital invested by funds: $146M → $121M (-$25.7M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$3.4M |
| 2 |
Millennium Management
New York
|
+$2.39M |
| 3 |
State Street
Boston,
Massachusetts
|
+$1.98M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$1.58M |
| 5 |
Mirae Asset Global Investments
Seoul,
South Korea
|
+$814K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$2.58M |
| 2 |
Mitsubishi UFJ Asset Management
Tokyo,
Japan
|
-$1.02M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$804K |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
-$749K |
| 5 |
Two Sigma Investments
New York
|
-$694K |
BNGO Hedge Fund Activity: Q4 2022 in Review
142 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Bionano Genomics (BNGO) for Q4 2022, worth a combined $121M — down 18% from $146M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new BNGO positions and 19 closed out — a net gain of 4 holders — while 50 added to existing stakes and 29 trimmed.
The largest buyer was BlackRock, adding an estimated $3.4M. The largest seller was Renaissance Technologies, exiting entirely with an estimated $2.58M sold.
- 142 institutional investors held Bionano Genomics (BNGO) as of Q4 2022, up from 140 in Q3 2022.
- Funds reported $121M of Bionano Genomics stock for Q4 2022, down 18% quarter-over-quarter.
- 23 funds opened new Bionano Genomics positions in Q4 2022 and 19 closed out, a net change of +4 holders.
- The largest Bionano Genomics buyer in Q4 2022 was BlackRock, an estimated $3.4M added.
- The largest Bionano Genomics seller in Q4 2022 was Renaissance Technologies, an estimated $2.58M sold.
Based on aggregated 13F filings for Q4 2022.